Log In
Print
BCIQ
Print
Print this Print this
 

RGB-286638

  Manage Alerts
Collapse Summary General Information
Company Agennix AG
DescriptionMulti-targeted kinase inhibitor
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today